Chris Maher

Chris Maher possesses extensive experience in executive leadership and investment banking, currently serving as Chief Development Officer (CDO) at Align ENT + Allergy and previously at OMS360. Prior roles include Director of Mergers and Acquisitions at DaVita Kidney Care and a progression of positions within SunTrust Robinson Humphrey, now known as Truist Securities, culminating in the role of Director in Consumer and Retail Investment Banking. Additional experience includes positions as Vice President, Associate, and Analyst within the Investment Banking sector.